img

Global Naldemedine Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Naldemedine Market Insights, Forecast to 2034

The global Naldemedine market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Naldemedine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Naldemedine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Naldemedine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key manufacturers of Naldemedine include Shionogi and Purdue Pharma etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes


This report presents an overview of global market for Naldemedine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Naldemedine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Naldemedine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Naldemedine sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2024. Identification of the major stakeholders in the global Naldemedine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2034. Evaluation and forecast the market size for Naldemedine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Shionogi and Purdue Pharma etc.



By Company


Shionogi
Purdue Pharma
Segment by Type
Self-production API
Outsourcing of API

Segment by Application


Hospital
Clinic
Drug Center
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Naldemedine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of Naldemedine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8China by type, by application sales and revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Naldemedine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Naldemedine Product Introduction
1.2 Market by Type
1.2.1 Global Naldemedine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Self-production API
1.2.3 Outsourcing of API
1.3 Market by Application
1.3.1 Global Naldemedine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Naldemedine Sales Estimates and Forecasts 2018-2034
2.2 Global Naldemedine Revenue by Region
2.2.1 Global Naldemedine Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global Naldemedine Revenue by Region (2018-2024)
2.2.3 Global Naldemedine Revenue by Region (2024-2034)
2.2.4 Global Naldemedine Revenue Market Share by Region (2018-2034)
2.3 Global Naldemedine Sales Estimates and Forecasts 2018-2034
2.4 Global Naldemedine Sales by Region
2.4.1 Global Naldemedine Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global Naldemedine Sales by Region (2018-2024)
2.4.3 Global Naldemedine Sales by Region (2024-2034)
2.4.4 Global Naldemedine Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Naldemedine Sales by Manufacturers
3.1.1 Global Naldemedine Sales by Manufacturers (2018-2024)
3.1.2 Global Naldemedine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Naldemedine in 2022
3.2 Global Naldemedine Revenue by Manufacturers
3.2.1 Global Naldemedine Revenue by Manufacturers (2018-2024)
3.2.2 Global Naldemedine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Naldemedine Revenue in 2022
3.3 Global Key Players of Naldemedine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Naldemedine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Naldemedine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Naldemedine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Naldemedine, Product Offered and Application
3.8 Global Key Manufacturers of Naldemedine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Naldemedine Sales by Type
4.1.1 Global Naldemedine Historical Sales by Type (2018-2024)
4.1.2 Global Naldemedine Forecasted Sales by Type (2024-2034)
4.1.3 Global Naldemedine Sales Market Share by Type (2018-2034)
4.2 Global Naldemedine Revenue by Type
4.2.1 Global Naldemedine Historical Revenue by Type (2018-2024)
4.2.2 Global Naldemedine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Naldemedine Revenue Market Share by Type (2018-2034)
4.3 Global Naldemedine Price by Type
4.3.1 Global Naldemedine Price by Type (2018-2024)
4.3.2 Global Naldemedine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Naldemedine Sales by Application
5.1.1 Global Naldemedine Historical Sales by Application (2018-2024)
5.1.2 Global Naldemedine Forecasted Sales by Application (2024-2034)
5.1.3 Global Naldemedine Sales Market Share by Application (2018-2034)
5.2 Global Naldemedine Revenue by Application
5.2.1 Global Naldemedine Historical Revenue by Application (2018-2024)
5.2.2 Global Naldemedine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Naldemedine Revenue Market Share by Application (2018-2034)
5.3 Global Naldemedine Price by Application
5.3.1 Global Naldemedine Price by Application (2018-2024)
5.3.2 Global Naldemedine Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Naldemedine Market Size by Type
6.1.1 US & Canada Naldemedine Sales by Type (2018-2034)
6.1.2 US & Canada Naldemedine Revenue by Type (2018-2034)
6.2 US & Canada Naldemedine Market Size by Application
6.2.1 US & Canada Naldemedine Sales by Application (2018-2034)
6.2.2 US & Canada Naldemedine Revenue by Application (2018-2034)
6.3 US & Canada Naldemedine Market Size by Country
6.3.1 US & Canada Naldemedine Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada Naldemedine Sales by Country (2018-2034)
6.3.3 US & Canada Naldemedine Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Naldemedine Market Size by Type
7.1.1 Europe Naldemedine Sales by Type (2018-2034)
7.1.2 Europe Naldemedine Revenue by Type (2018-2034)
7.2 Europe Naldemedine Market Size by Application
7.2.1 Europe Naldemedine Sales by Application (2018-2034)
7.2.2 Europe Naldemedine Revenue by Application (2018-2034)
7.3 Europe Naldemedine Market Size by Country
7.3.1 Europe Naldemedine Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe Naldemedine Sales by Country (2018-2034)
7.3.3 Europe Naldemedine Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Naldemedine Market Size
8.1.1 China Naldemedine Sales (2018-2034)
8.1.2 China Naldemedine Revenue (2018-2034)
8.2 China Naldemedine Market Size by Application
8.2.1 China Naldemedine Sales by Application (2018-2034)
8.2.2 China Naldemedine Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Naldemedine Market Size by Type
9.1.1 Asia Naldemedine Sales by Type (2018-2034)
9.1.2 Asia Naldemedine Revenue by Type (2018-2034)
9.2 Asia Naldemedine Market Size by Application
9.2.1 Asia Naldemedine Sales by Application (2018-2034)
9.2.2 Asia Naldemedine Revenue by Application (2018-2034)
9.3 Asia Naldemedine Sales by Region
9.3.1 Asia Naldemedine Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia Naldemedine Revenue by Region (2018-2034)
9.3.3 Asia Naldemedine Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Naldemedine Market Size by Type
10.1.1 Middle East, Africa and Latin America Naldemedine Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Naldemedine Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Naldemedine Market Size by Application
10.2.1 Middle East, Africa and Latin America Naldemedine Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Naldemedine Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Naldemedine Sales by Country
10.3.1 Middle East, Africa and Latin America Naldemedine Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Naldemedine Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Naldemedine Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Shionogi
11.1.1 Shionogi Company Information
11.1.2 Shionogi Overview
11.1.3 Shionogi Naldemedine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Shionogi Naldemedine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shionogi Recent Developments
11.2 Purdue Pharma
11.2.1 Purdue Pharma Company Information
11.2.2 Purdue Pharma Overview
11.2.3 Purdue Pharma Naldemedine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Purdue Pharma Naldemedine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Purdue Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Naldemedine Industry Chain Analysis
12.2 Naldemedine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Naldemedine Production Mode & Process
12.4 Naldemedine Sales and Marketing
12.4.1 Naldemedine Sales Channels
12.4.2 Naldemedine Distributors
12.5 Naldemedine Customers
13 Market Dynamics
13.1 Naldemedine Industry Trends
13.2 Naldemedine Market Drivers
13.3 Naldemedine Market Challenges
13.4 Naldemedine Market Restraints
14 Key Findings in The Global Naldemedine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Naldemedine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Self-production API
Table 3. Major Manufacturers of Outsourcing of API
Table 4. Global Naldemedine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Naldemedine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Naldemedine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Naldemedine Revenue by Region (2024-2034) & (US$ Million)
Table 8. Global Naldemedine Revenue Market Share by Region (2018-2024)
Table 9. Global Naldemedine Revenue Market Share by Region (2024-2034)
Table 10. Global Naldemedine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global Naldemedine Sales by Region (2018-2024) & (K Pcs)
Table 12. Global Naldemedine Sales by Region (2024-2034) & (K Pcs)
Table 13. Global Naldemedine Sales Market Share by Region (2018-2024)
Table 14. Global Naldemedine Sales Market Share by Region (2024-2034)
Table 15. Global Naldemedine Sales by Manufacturers (2018-2024) & (K Pcs)
Table 16. Global Naldemedine Sales Share by Manufacturers (2018-2024)
Table 17. Global Naldemedine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Naldemedine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Naldemedine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Naldemedine Price by Manufacturers 2018-2024 (USD/Pcs)
Table 21. Global Naldemedine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Naldemedine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Naldemedine as of 2022)
Table 23. Global Key Manufacturers of Naldemedine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Naldemedine, Product Offered and Application
Table 25. Global Key Manufacturers of Naldemedine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Naldemedine Sales by Type (2018-2024) & (K Pcs)
Table 28. Global Naldemedine Sales by Type (2024-2034) & (K Pcs)
Table 29. Global Naldemedine Sales Share by Type (2018-2024)
Table 30. Global Naldemedine Sales Share by Type (2024-2034)
Table 31. Global Naldemedine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Naldemedine Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Naldemedine Revenue Share by Type (2018-2024)
Table 34. Global Naldemedine Revenue Share by Type (2024-2034)
Table 35. Naldemedine Price by Type (2018-2024) & (USD/Pcs)
Table 36. Global Naldemedine Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 37. Global Naldemedine Sales by Application (2018-2024) & (K Pcs)
Table 38. Global Naldemedine Sales by Application (2024-2034) & (K Pcs)
Table 39. Global Naldemedine Sales Share by Application (2018-2024)
Table 40. Global Naldemedine Sales Share by Application (2024-2034)
Table 41. Global Naldemedine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Naldemedine Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Naldemedine Revenue Share by Application (2018-2024)
Table 44. Global Naldemedine Revenue Share by Application (2024-2034)
Table 45. Naldemedine Price by Application (2018-2024) & (USD/Pcs)
Table 46. Global Naldemedine Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 47. US & Canada Naldemedine Sales by Type (2018-2024) & (K Pcs)
Table 48. US & Canada Naldemedine Sales by Type (2024-2034) & (K Pcs)
Table 49. US & Canada Naldemedine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Naldemedine Revenue by Type (2024-2034) & (US$ Million)
Table 51. US & Canada Naldemedine Sales by Application (2018-2024) & (K Pcs)
Table 52. US & Canada Naldemedine Sales by Application (2024-2034) & (K Pcs)
Table 53. US & Canada Naldemedine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Naldemedine Revenue by Application (2024-2034) & (US$ Million)
Table 55. US & Canada Naldemedine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 56. US & Canada Naldemedine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Naldemedine Revenue by Country (2024-2034) & (US$ Million)
Table 58. US & Canada Naldemedine Sales by Country (2018-2024) & (K Pcs)
Table 59. US & Canada Naldemedine Sales by Country (2024-2034) & (K Pcs)
Table 60. Europe Naldemedine Sales by Type (2018-2024) & (K Pcs)
Table 61. Europe Naldemedine Sales by Type (2024-2034) & (K Pcs)
Table 62. Europe Naldemedine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Naldemedine Revenue by Type (2024-2034) & (US$ Million)
Table 64. Europe Naldemedine Sales by Application (2018-2024) & (K Pcs)
Table 65. Europe Naldemedine Sales by Application (2024-2034) & (K Pcs)
Table 66. Europe Naldemedine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Naldemedine Revenue by Application (2024-2034) & (US$ Million)
Table 68. Europe Naldemedine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 69. Europe Naldemedine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Naldemedine Revenue by Country (2024-2034) & (US$ Million)
Table 71. Europe Naldemedine Sales by Country (2018-2024) & (K Pcs)
Table 72. Europe Naldemedine Sales by Country (2024-2034) & (K Pcs)
Table 73. China Naldemedine Sales by Type (2018-2024) & (K Pcs)
Table 74. China Naldemedine Sales by Type (2024-2034) & (K Pcs)
Table 75. China Naldemedine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Naldemedine Revenue by Type (2024-2034) & (US$ Million)
Table 77. China Naldemedine Sales by Application (2018-2024) & (K Pcs)
Table 78. China Naldemedine Sales by Application (2024-2034) & (K Pcs)
Table 79. China Naldemedine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Naldemedine Revenue by Application (2024-2034) & (US$ Million)
Table 81. Asia Naldemedine Sales by Type (2018-2024) & (K Pcs)
Table 82. Asia Naldemedine Sales by Type (2024-2034) & (K Pcs)
Table 83. Asia Naldemedine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Naldemedine Revenue by Type (2024-2034) & (US$ Million)
Table 85. Asia Naldemedine Sales by Application (2018-2024) & (K Pcs)
Table 86. Asia Naldemedine Sales by Application (2024-2034) & (K Pcs)
Table 87. Asia Naldemedine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Naldemedine Revenue by Application (2024-2034) & (US$ Million)
Table 89. Asia Naldemedine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 90. Asia Naldemedine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Naldemedine Revenue by Region (2024-2034) & (US$ Million)
Table 92. Asia Naldemedine Sales by Region (2018-2024) & (K Pcs)
Table 93. Asia Naldemedine Sales by Region (2024-2034) & (K Pcs)
Table 94. Middle East, Africa and Latin America Naldemedine Sales by Type (2018-2024) & (K Pcs)
Table 95. Middle East, Africa and Latin America Naldemedine Sales by Type (2024-2034) & (K Pcs)
Table 96. Middle East, Africa and Latin America Naldemedine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Naldemedine Revenue by Type (2024-2034) & (US$ Million)
Table 98. Middle East, Africa and Latin America Naldemedine Sales by Application (2018-2024) & (K Pcs)
Table 99. Middle East, Africa and Latin America Naldemedine Sales by Application (2024-2034) & (K Pcs)
Table 100. Middle East, Africa and Latin America Naldemedine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Naldemedine Revenue by Application (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America Naldemedine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 103. Middle East, Africa and Latin America Naldemedine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Naldemedine Revenue by Country (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Naldemedine Sales by Country (2018-2024) & (K Pcs)
Table 106. Middle East, Africa and Latin America Naldemedine Sales by Country (2024-2034) & (K Pcs)
Table 107. Shionogi Company Information
Table 108. Shionogi Description and Major Businesses
Table 109. Shionogi Naldemedine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 110. Shionogi Naldemedine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Shionogi Recent Developments
Table 112. Purdue Pharma Company Information
Table 113. Purdue Pharma Description and Major Businesses
Table 114. Purdue Pharma Naldemedine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 115. Purdue Pharma Naldemedine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Purdue Pharma Recent Developments
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Naldemedine Distributors List
Table 120. Naldemedine Customers List
Table 121. Naldemedine Market Trends
Table 122. Naldemedine Market Drivers
Table 123. Naldemedine Market Challenges
Table 124. Naldemedine Market Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Naldemedine Product Picture
Figure 2. Global Naldemedine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Naldemedine Market Share by Type in 2022 & 2034
Figure 4. Self-production API Product Picture
Figure 5. Outsourcing of API Product Picture
Figure 6. Global Naldemedine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Naldemedine Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Drug Center
Figure 11. Other
Figure 12. Naldemedine Report Years Considered
Figure 13. Global Naldemedine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Naldemedine Revenue 2018-2034 (US$ Million)
Figure 15. Global Naldemedine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Naldemedine Revenue Market Share by Region (2018-2034)
Figure 17. Global Naldemedine Sales 2018-2034 ((K Pcs)
Figure 18. Global Naldemedine Sales Market Share by Region (2018-2034)
Figure 19. US & Canada Naldemedine Sales YoY (2018-2034) & (K Pcs)
Figure 20. US & Canada Naldemedine Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Naldemedine Sales YoY (2018-2034) & (K Pcs)
Figure 22. Europe Naldemedine Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Naldemedine Sales YoY (2018-2034) & (K Pcs)
Figure 24. China Naldemedine Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Asia (excluding China) Naldemedine Sales YoY (2018-2034) & (K Pcs)
Figure 26. Asia (excluding China) Naldemedine Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Naldemedine Sales YoY (2018-2034) & (K Pcs)
Figure 28. Middle East, Africa and Latin America Naldemedine Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Naldemedine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Naldemedine in the World: Market Share by Naldemedine Revenue in 2022
Figure 31. Global Naldemedine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Naldemedine Sales Market Share by Type (2018-2034)
Figure 33. Global Naldemedine Revenue Market Share by Type (2018-2034)
Figure 34. Global Naldemedine Sales Market Share by Application (2018-2034)
Figure 35. Global Naldemedine Revenue Market Share by Application (2018-2034)
Figure 36. US & Canada Naldemedine Sales Market Share by Type (2018-2034)
Figure 37. US & Canada Naldemedine Revenue Market Share by Type (2018-2034)
Figure 38. US & Canada Naldemedine Sales Market Share by Application (2018-2034)
Figure 39. US & Canada Naldemedine Revenue Market Share by Application (2018-2034)
Figure 40. US & Canada Naldemedine Revenue Share by Country (2018-2034)
Figure 41. US & Canada Naldemedine Sales Share by Country (2018-2034)
Figure 42. U.S. Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Naldemedine Sales Market Share by Type (2018-2034)
Figure 45. Europe Naldemedine Revenue Market Share by Type (2018-2034)
Figure 46. Europe Naldemedine Sales Market Share by Application (2018-2034)
Figure 47. Europe Naldemedine Revenue Market Share by Application (2018-2034)
Figure 48. Europe Naldemedine Revenue Share by Country (2018-2034)
Figure 49. Europe Naldemedine Sales Share by Country (2018-2034)
Figure 50. Germany Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 51. France Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 52. U.K. Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 53. Italy Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 54. Russia Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 55. China Naldemedine Sales Market Share by Type (2018-2034)
Figure 56. China Naldemedine Revenue Market Share by Type (2018-2034)
Figure 57. China Naldemedine Sales Market Share by Application (2018-2034)
Figure 58. China Naldemedine Revenue Market Share by Application (2018-2034)
Figure 59. Asia Naldemedine Sales Market Share by Type (2018-2034)
Figure 60. Asia Naldemedine Revenue Market Share by Type (2018-2034)
Figure 61. Asia Naldemedine Sales Market Share by Application (2018-2034)
Figure 62. Asia Naldemedine Revenue Market Share by Application (2018-2034)
Figure 63. Asia Naldemedine Revenue Share by Region (2018-2034)
Figure 64. Asia Naldemedine Sales Share by Region (2018-2034)
Figure 65. Japan Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 66. South Korea Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 67. China Taiwan Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 68. Southeast Asia Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 69. India Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Naldemedine Sales Market Share by Type (2018-2034)
Figure 71. Middle East, Africa and Latin America Naldemedine Revenue Market Share by Type (2018-2034)
Figure 72. Middle East, Africa and Latin America Naldemedine Sales Market Share by Application (2018-2034)
Figure 73. Middle East, Africa and Latin America Naldemedine Revenue Market Share by Application (2018-2034)
Figure 74. Middle East, Africa and Latin America Naldemedine Revenue Share by Country (2018-2034)
Figure 75. Middle East, Africa and Latin America Naldemedine Sales Share by Country (2018-2034)
Figure 76. Brazil Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 77. Mexico Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 78. Turkey Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 79. Israel Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 80. GCC Countries Naldemedine Revenue (2018-2034) & (US$ Million)
Figure 81. Naldemedine Value Chain
Figure 82. Naldemedine Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed